Virax Biolabs Extends Exclusive Distribution Deal for Mpox Virus Test Kits; Shares Rise Pre-Bell

MT Newswires Live09-16

Virax Biolabs (VRAX) said Monday it has extended its exclusive distribution agreement with Cosmos Health (COSM) to commercialize Mpox virus test kits in Gulf countries.

Shares of Virax rose more than 38% in recent premarket activity. Cosmos Health added over 6% recently.

Virax had previously signed an exclusive distribution deal for Greece and Cyprus, with a non-exclusive agreement to distribute throughout Europe, the company said. The latest extension covers the Gulf Cooperation Council, including Bahrain, Saudi Arabia and the United Arab Emirates.

Financial details of the contract extension were not disclosed.

Price: 3.5900, Change: +1.00, Percent Change: +38.61

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2467909810?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-16 21:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2467909810","market":"sh","top_or_hot":-1,"title":"Virax Biolabs Extends Exclusive Distribution Deal for Mpox Virus Test Kits; Shares Rise Pre-Bell","media":"MT Newswires Live","content":"<html><body><p> Virax Biolabs (VRAX) said Monday it has extended its exclusive distribution agreement with Cosmos Health (COSM) to commercialize Mpox virus test kits in Gulf countries.</p><p>Shares of Virax rose more than 38% in recent premarket activity. Cosmos Health added over 6% recently.</p><p>Virax had previously signed an exclusive distribution deal for Greece and Cyprus, with a non-exclusive agreement to distribute throughout Europe, the company said. The latest extension covers the Gulf Cooperation Council, including Bahrain, Saudi Arabia and the United Arab Emirates.</p><p>Financial details of the contract extension were not disclosed.</p><p>Price: 3.5900, Change: +1.00, Percent Change: +38.61</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Virax Biolabs Extends Exclusive Distribution Deal for Mpox Virus Test Kits; Shares Rise Pre-Bell</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVirax Biolabs Extends Exclusive Distribution Deal for Mpox Virus Test Kits; Shares Rise Pre-Bell\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-16 21:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Virax Biolabs (VRAX) said Monday it has extended its exclusive distribution agreement with Cosmos Health (COSM) to commercialize Mpox virus test kits in Gulf countries.Shares of Virax rose more than ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRAX","symbol_name":"Virax Biolabs Group Limited","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2467909810","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2467909810","pubTimestamp":1726491891,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Virax Biolabs  said Monday it has extended its exclusive distribution agreement with Cosmos Health  to commercialize Mpox virus test kits in Gulf countries.Shares of Virax rose more than 38% in recent premarket activity. Cosmos Health added over 6% recently.Virax had previously signed an exclusive distribution deal for Greece and Cyprus, with a non-exclusive agreement to distribute throughout Europe, the company said. The latest extension covers the Gulf Cooperation Council, including Bahrain, Saudi Arabia and the United Arab Emirates.Financial details of the contract extension were not disclosed.Price: 3.5900, Change: +1.00, Percent Change: +38.61","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VRAX":"Virax Biolabs Group Limited","COSM":"COSMOS HEALTH INC","BK4583":"猴痘概念","BK4175":"保健护理产品经销商"},"translate_title":"Virax Biolabs延长Mpox病毒检测试剂盒的独家分销协议；盘前股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COSM":0.9,"VRAX":0.9},"content_text":"Virax Biolabs (VRAX) said Monday it has extended its exclusive distribution agreement with Cosmos Health (COSM) to commercialize Mpox virus test kits in Gulf countries.Shares of Virax rose more than 38% in recent premarket activity. Cosmos Health added over 6% recently.Virax had previously signed an exclusive distribution deal for Greece and Cyprus, with a non-exclusive agreement to distribute throughout Europe, the company said. The latest extension covers the Gulf Cooperation Council, including Bahrain, Saudi Arabia and the United Arab Emirates.Financial details of the contract extension were not disclosed.Price: 3.5900, Change: +1.00, Percent Change: +38.61","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2467909810"}